DRTS NASDAQ
Alpha Tau Medical Ltd
1W: +3.2%
1M: -10.2%
3M: +20.8%
YTD: +179.7%
1Y: +219.4%
3Y: +308.2%
5Y: +36.3%
$13.51
+0.62 (+4.81%)
Weekly Expected Move ±6.6%
$11
$12
$13
$14
$15
Credit Risk of going bust: lower than 70% of companies Debt: 1.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.01 (down 99.9%), Alpha Tau Medical Ltd would be worth roughly what it owes.
Total debt $15.2M against a stock market value of $1.25B.
Distance to default 7.56 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $3.4M (short-term plus half of long-term), stock volatility 75.2%; Altman Z'' -3.54. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $15.2M against a stock market value of $1.25B.
Distance to default 7.56 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $3.4M (short-term plus half of long-term), stock volatility 75.2%; Altman Z'' -3.54. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.2B
52W Range3.43-15.79
Volume341,843
Avg Volume617,885
Beta1.22
Dividend—
Analyst Ratings
Company Info
CEOUzi Sofer
Employees121
SectorHealthcare
IndustryBiotechnology
IPO Date2021-03-08
Websitealphatau.com
Kiryat HaMada St. 5
Jerusalem, JM 9777605
IL
Jerusalem, JM 9777605
IL
972 3 577 4115
About Alpha Tau Medical Ltd
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.
Latest News
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Stock Has Average Price Target of $15.40 According to Analysts
Alpha Tau Medical (NASDAQ:DRTS) Stock Falls 1% – Should You Sell?
Alpha Tau Medical (NASDAQ:DRTSW) Stock Falls 0.8% – Here’s What Happened
Alpha Tau Medical (NASDAQ:DRTS) Sets New 52-Week High – Time to Buy?
HC Wainwright Expects Weaker Earnings for Alpha Tau Medical
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Levy Raphi | S-Sale | 2,871 | $15.00 | 2026-08-21 |
| Levy Raphi | M-Exempt | 17,730 | $2.98 | 2026-08-11 |
| Levy Raphi | S-Sale | 17,730 | $14.00 | 2026-08-11 |
| Levy Raphi | M-Exempt | 2,270 | $2.98 | 2026-07-06 |
| Levy Raphi | S-Sale | 2,270 | $14.00 | 2026-07-06 |